Steven Hodak, MD

  • Specialty: Endocrinology
  • Language: English
  • Phone: 212-481-1350

About Me

I’ve always gravitated toward medicine, even in high school, when I was fascinated by physiology, which is the study of how the body works. I chose to specialize in endocrinology because of my particular interest in the role of hormones—molecules made by glands, including the pituitary and thyroid. Hormones carry messages to organs about numerous body functions, from converting food into energy to our response to stress.

My specialty is in diagnosing and treating people with pituitary and adrenal disorders, thyroid cancer, and bone and calcium conditions, such as osteoporosis and hyperparathyroidism.

The pituitary is often called the “master gland,” because of its control of the thyroid, testes, ovaries, adrenal glands, and more. I specialize in treating pituitary disorders. These include Cushing syndrome, in which there is an overproduction of cortisol, as well as acromegaly, in which there is an overproduction of growth hormone, and hyperprolactinemia and prolactinoma, or the overproduction of prolactin.

Though thyroid nodules are common, thyroid cancer is not. Using methods such as fine needle aspiration biopsy and advanced molecular genetic tests, many of which I have helped to develop, we have significantly improved our ability to diagnose, manage, and observe the growth of thyroid cancer, especially when the cancer would otherwise be undetectable.

I am a national expert in molecular thyroid diagnosis, which can determine which nodules have a very low risk of containing thyroid cancer, dramatically reducing the need for diagnostic thyroid surgery. This method can also help us identify the genetic makeup of thyroid cancer cells, ensuring the best possible match between the treatment and the specific type of gene it’s targeting.

I also treat patients with low bone mass and osteoporosis who have an increased risk of fracture. Whether this is caused by a correctable condition or simply due to aging, appropriate diagnosis and treatment can dramatically reduce the risk for potentially devastating fractures of the hip and spine that can lead to loss of mobility or even death.

My patients are my top priority, and I am dedicated to providing accessible and compassionate treatment to prevent the condition from diminishing your quality of life, both now and in the future.

Conditions and Treatments

thyroid cancer, thyroid nodule, thyroid diseases, pituitary disorders, multiple endocrine neoplasia, prolactinoma, cushing's syndrome, acromegaly, metabolic bone disease, graves' disease, adrenal gland disorders, pheochromocytoma, diabetes insipidus, adrenal tumor, hyperthyroidism, neuroendocrine tumor, autoimmune thyroid disease, pituitary tumor, hypopituitarism, osteoporosis, calcium disorders, hypothyroidism, thyroiditis, parathyroid disease, thyroid cancer lymphoma, thyroglossal duct cyst, pituitary adenoma, postpartum thyroiditis, subacute thyroiditis, hypogonadotropic hypogonadism, silent thyroiditis, hypoparathyroidism, congenital adrenal hyperplasia, chronic thyroiditis, hyperparathyroidism, galactorrhea, craniopharyngioma, adrenal insufficiency
Show More Conditions


  • Professor, Department of Medicine
  • Assoc Dir of Clinical Aff, Div of Endocrinology
  • Director, Medicine Faculty Group Practice
  • Director, Glycemic Control at Tisch Hos
  • Chief, Endocrinology at Tisch Hospital
Board Certifications
  • American Board of Internal Medicine (Endocrinology, Diabetes & Metabolism), 2005
  • American Board of Internal Medicine - Internal Medicine, 2004
Education and Training
  • Fellowship, Georgetown University Hospital, 2005
  • Residency, Georgetown University Hospital, Endocrinology & Metabolism, 2003
  • MD from Georgetown University, 1999

Locations and Appointments

70 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Affinity
  • Affinity Exchange- Essential
  • Alphacare
  • Cigna EPO/POS
  • Cigna PPO
  • ElderPlan
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield HealthPlus
  • Empire Blue Cross Blue Shield HealthPlus Essential
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis Child Health
  • Fidelis Essential
  • Fidelis Exchange
  • Fidelis Family Health
  • Fidelis Medicaid
  • Fidelis Medicare
  • HIP Access I
  • HIP Access II
  • HIP Child Health
  • HIP Essential
  • HIP Family Health
  • HIP Medicaid
  • HIP Medicare
  • Healthfirst
  • Healthfirst Essential
  • Humana Medicare
  • Local 1199 PPO
  • MagnaCare PPO
  • Medicare
  • MetroPlus Child Health
  • MetroPlus Essential
  • MetroPlus Exchange Plans
  • MetroPlus Family Health
  • MetroPlus Medicaid
  • MetroPlus Medicare
  • MultiPlan/PHCS PPO
  • NY Medicaid
  • NYS Empire Plan
  • Oscar
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • Tricare
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare Core and Charter
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • Visiting Nurse Service (VNS) Medicare
  • WellCare Child Health
  • WellCare Family Health
  • WellCare Medicaid
  • WellCare Medicare
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.
NYU Diabetes & Endocrine Associates

530 1st Avenue, Suite 5F
New York, NY 10016

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

“My research focuses on the creation of genetic tests to better diagnose and treat people with thyroid cancer.”

Steven Hodak, MD Endocrinologist

My Research

Dr. Hodaks clinical research focuses on the use of molecular genetic tools to improve diagnostic yield of thyroid nodule fine-needle aspiration biopsies. These novel techniques allow better risk stratification of thyroid cancer patients and identify those thyroid nodules most likely to be benign so they may be followed conservatively without surgery. These important molecular tools spare many patients from unnecessary thyroid surgery, and minimize associated human and economic costs. Dr. Hodak has co-authored numerous peer-reviewed articles in this field, performs hundreds of thyroid fine-needle biopsies annually, and has developed patient databases and tissue biorepositories required for successful translational research. Through his work, Dr. Hodak has become nationally recognized in the field of thyroid cancer and molecular diagnostics, serving on professional committees and speaking widely. He has been a past thyroid section chair for the Endocrine Society's Clinical Endocrinology Update Steering Committee and continues to serve on the American Thyroid Association Clinical Affairs Committee where he authored that groups position statement regarding clinical use of molecular genetic testing for thyroid cancer diagnosis. He is a Best Doctor in New York and has been recognized annually as one of Americas Best Doctors for over a decade.


  • Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A changing paradigm in thyroid surgical pathology and implications for thyroid cytopathology

    Baloch, Zubair W; Seethala, Raja R; Faquin, William C; Papotti, Mauro G; Basolo, Fulvio; Fadda, Guido; Randolph, Gregory W; Hodak, Steven P; Nikiforov, Yuri E; Mandel, Susan J
    Cancer cytopathology. 2016 May 20. ?-?

  • Changing the Cancer Diagnosis - the Case of Follicular Variant of Papillary Thyroid Cancer Primum, Non Nocere and NIFTP

    Hodak, Steven; Tuttle, R Michael Md; Maytal, Guy; Nikiforov, Yuri E; Randolph, Gregory
    Thyroid. 2016 May 16. ?-?

  • Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors

    Nikiforov, Yuri E; Seethala, Raja R; Tallini, Giovanni; Baloch, Zubair W; Basolo, Fulvio; Thompson, Lester D R; Barletta, Justine A; Wenig, Bruce M; Al Ghuzlan, Abir; Kakudo, Kennichi; Giordano, Thomas J; Alves, Venancio A; Khanafshar, Elham; Asa, Sylvia L; El-Naggar, Adel K; Gooding, William E; Hodak, Steven P; Lloyd, Ricardo V; Maytal, Guy; Mete, Ozgur; Nikiforova, Marina N; Nose, Vania; Papotti, Mauro; Poller, David N; Sadow, Peter M; Tischler, Arthur S; Tuttle, R Michael; Wall, Kathryn B; LiVolsi, Virginia A; Randolph, Gregory W; Ghossein, Ronald A
    JAMA oncology. 2016 Apr 14. ?-?

Read All Publications (41)